Immunotherapy “Shock” with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma

by Paul Zarogoulidis, Haidong Huang, Theodora Tsiouda, Chrysa Sardeli, Georgia Trakada, Lemonia Veletza, Anastasios Kallianos, Christoforos Kosmidis, Aggeliki Rapti, Liana Papaemmanouil, Dimitrios Hatzibougias, Dimitrios Drougas, Chong Bai, Wolfgang Hohenforst-Schmidt
Published 2017-01-01

Immunotherapy “Shock” a case series of PD-L1 100% and pembrolizumab first-line treatment

by Paul Zarogoulidis, Evaggelia Athanasiou, Theodora Tsiouda, Dimitrios Hatzibougias, Haidong Huang, Chong Bai, Georgia Trakada, Lemonia Veletza, Anastasios Kallianos, Christoforos Kosmidis, Nikolaos Barbetakis, Dimitrios Paliouras, Aggeliki Rapti, Dimitrios Drougas, Wolfgang Hohenforst-Schmidt
Published 2017-01-01

Psoriatic arthritis due to nivolumab administration a case report and review of the literature

by Konstantinos Sapalidis, Christoforos Kosmidis, Nikolaos Michalopoulos, Charilaos Koulouris, Stylianos Mantalobas, Dimitrios Giannakidis, Alexandru Munteanu, Valeriu Surlin, Stella Laskou, Paul Zarogoulidis, Dimitrios Drougas, Crysanthi Sardeli, Chrysanthi Karapantzou, Ilias Karapantzos, Wolfgang Hohenforst-Schmidt, Haidong Huang, Isaak Kesisoglou
Published 2018-01-01